Senate Democrats and the Biden administration dropped plans to set drug price caps based on the amount paid in other high-income countries, during talks years ago to push through the law that empowered Medicare to negotiate down the cost of prescription medications.

President Donald Trump is attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term.

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a new evaluation tool.

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the prices of medication abroad, sources told CBS News.

This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than they are in other high-income countries.

The executive order Trump is promising will direct the Department of Health and Human Services to tie what Medicare pays for medications administered in a doctor’s office to the lowest price paid by o

President Donald Trump is expected to sign an executive order soon to lower the cost of prescription drugs for Medicare beneficiaries. The order would implement a “most favored nation” policy, tying the prices of certain Medicare-covered drugs to those paid by other developed countries.

The administration plans to "eliminate funding that had been used to carry out non-statutory, wasteful and woke activities."

As Maryland negotiates a new health care system, federal government may cut back state’s control over Medicare costs.

Trump admin officials pen NYT op-ed describing welfare restrictions as an ‘opportunity’: ‘Work is transformative’ - Administration claims work restrictions will boost labor force participation and sav

Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more than those in other countries.